Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021-Reference-Cited by-同舟云学术

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

Published:2021-10-12 Issue:14 Volume:326 Page:1436
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Uyoga Sophie¹,Adetifa Ifedayo M. O.¹,Otiende Mark¹,Yegon Christine²,Agweyu Ambrose¹,Warimwe George M.¹,Scott J. Anthony G.¹

Affiliation:

1. KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

2. Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2784014/jama_uyoga_2021_ld_210059_1633976038.42965.pdf

Reference5 articles.

1. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.;Uyoga;Science,2021

2. Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.;Adetifa;Nat Commun,2021

3. Seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 among healthcare workers in Kenya.;Etyang;Clin Infect Dis,2021

4. Weekly national influenza and COVID-19 surveillance report: week 24 report (up to week 23 data). Public Health England. Accessed June 17, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/994577/Weekly_Flu_and_COVID-19_report_w24.pdf

5. Mattiuzzo? G, Bentley? EM, Hassall? M, . Establishment of the WHO International Standard and Reference Panel for Anti-SARS-CoV-2 Antibody. World Health Organization; 2020.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021–November 2022;Frontiers in Immunology;2024-03-26

2. Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021;Gates Open Research;2023-10-09

3. SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022;Influenza and Other Respiratory Viruses;2023-09

4. Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study;Wellcome Open Research;2023-08-17

5. Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021;Gates Open Research;2023-07-04